Master of Pharmacetical Regulatory Affairs

The MPRA – Master of Pharmaceutical Regulatory Affairs was established by March 1, 2007 at The Faculty of Pharmaceutical Sciences, University of Copenhagen.

In the interests of bridging international pharmaceutical development and approval The Faculty of Pharmaceutical Sciences in cooperation with Medicademy offers a master’s programme in Pharmaceutical Regulatory Affairs.

The aim of the master’s programme is to provide participants with solid theoretical and practical up to date knowledge in international regulatory affairs related to pharmaceutical, biological and biotech product development.

The master’s programme is designed for professionals who are employed in regulatory affairs with responsibilities in pharmaceutical/biotech regulatory affairs. The programme is an opportunity for participants to establish valuable networks with colleagues and teachers from around the world. The master’s programme is designed for combination with a busy job.

The MPRA master’s programme is a 2-6 year part-time program equivalent to 1 year of full-time study. The MPRA-programme consists of 8 compulsory courses (see below), a number of elective courses and a master's project.

It is possible to participate in individual courses as a freelance student.

Compulsory courses: 32.5 ECTS-credits
Elective courses:        10-15 ETCS -credits
Master's thesis:          12,5-17,5 ETCS-credits
In total:                        60 ECTS-credits

The 8 Compulsory courses:
Introductory Course at University of Copenhagen
Medicademy RA Module 1
Medicademy RA Module 2
Medicademy RA Module 5 
Medicademy RA Module 7
Medicademy RA Module 8
Medicademy RA Module 9
Medicademy RA Module 11

For further information on the MPRA please visit: www.farma.ku.dk/mpra